Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,268,000 | 241,000 | 11,845,000 | 9,373,000 | 5,421,000 |
| Depreciation Amortization | 4,387,000 | 2,127,000 | 8,467,000 | 6,310,000 | 4,105,000 |
| Income taxes - deferred | -635,000 | -267,000 | -1,931,000 | -1,415,000 | -794,000 |
| Accounts receivable | -275,000 | -195,000 | -1,455,000 | -1,039,000 | -1,396,000 |
| Accounts payable and accrued liabilities | 1,123,000 | -451,000 | 1,769,000 | 491,000 | -448,000 |
| Other Working Capital | -430,000 | -939,000 | -244,000 | -1,091,000 | -2,525,000 |
| Other Operating Activity | 4,074,000 | 3,677,000 | 6,492,000 | 4,886,000 | 5,550,000 |
| Operating Cash Flow | $10,512,000 | $4,193,000 | $24,943,000 | $17,515,000 | $9,913,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -353,000 | -175,000 | -695,000 | -482,000 | -305,000 |
| Net Acquisitions | -513,000 | -353,000 | -794,000 | -494,000 | -394,000 |
| Purchase Of Investment | -35,000 | -19,000 | -1,438,000 | -1,428,000 | -1,411,000 |
| Sale Of Investment | 36,000 | 22,000 | 1,530,000 | 1,460,000 | 50,000 |
| Other Investing Activity | 25,000 | 26,000 | 774,000 | 769,000 | 599,000 |
| Investing Cash Flow | $-840,000 | $-499,000 | $-623,000 | $-175,000 | $-1,461,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 2,000,000 | 2,000,000 | 2,000,000 |
| Debt Repayment | -2,353,000 | -1,351,000 | -14,433,000 | -7,582,000 | -4,881,000 |
| Common Stock Issued | 113,000 | 65,000 | 262,000 | 209,000 | 198,000 |
| Common Stock Repurchased | -1,965,000 | -1,955,000 | -1,487,000 | -1,483,000 | -1,479,000 |
| Dividend Paid | -5,286,000 | -2,661,000 | -10,043,000 | -7,537,000 | -5,033,000 |
| Other Financing Activity | -621,000 | -290,000 | -1,102,000 | -776,000 | -456,000 |
| Financing Cash Flow | $-10,112,000 | $-6,192,000 | $-24,803,000 | $-15,169,000 | $-9,651,000 |
| Exchange Rate Effect | -2,000 | 8,000 | -62,000 | -85,000 | -26,000 |
| Beginning Cash Position | 9,201,000 | 9,201,000 | 9,746,000 | 9,746,000 | 9,746,000 |
| End Cash Position | 8,759,000 | 6,711,000 | 9,201,000 | 11,832,000 | 8,521,000 |
| Net Cash Flow | $-442,000 | $-2,490,000 | $-545,000 | $2,086,000 | $-1,225,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,512,000 | 4,193,000 | 24,943,000 | 17,515,000 | 9,913,000 |
| Capital Expenditure | -353,000 | -175,000 | -695,000 | -482,000 | -305,000 |
| Free Cash Flow | 10,159,000 | 4,018,000 | 24,248,000 | 17,033,000 | 9,608,000 |